EAGLE PHARMACEUTICALS, INC. Annual Earnings Per Share, Diluted in USD/shares from 2013 to 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2013 to 2022.
  • Eagle Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2023 was 0.39 USD/shares.
  • Eagle Pharmaceuticals, Inc. Earnings Per Share, Diluted for the twelve months ending June 30, 2023 was 0.89 USD/shares, a 49.7% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2022 was 2.73 USD/shares.
  • Eagle Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2021 was -0.66 USD/shares, a 176% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2020 was 0.87 USD/shares, a 13.9% decline from 2019.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.